Jean‐Paul Sculier
- Pulmonary and Respiratory Medicine top 0.2%
- Oncology top 0.5%
- Molecular Biology top 5%
- Epidemiology top 2%
- Radiology, Nuclear Medicine and Imaging top 1%
- Co-authors
- Jean KlášterskýMarianne PaesmansThierry BerghmansAnne‐Pascale MeertCéline MascauxP LibertG. BureauJ Thiriaux
- Topics
- Lung Cancer Treatments and Mutations (94 papers)Lung Cancer Research Studies (82 papers)Lung Cancer Diagnosis and Treatment (64 papers)
- Partner nations
- BelgiumFranceUnited States
In The Last Decade
Jean‐Paul Sculier
215 papers receiving 7.7k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Pulmonary and Respiratory Medicine 4.7k
- Oncology 4.3k
- Molecular Biology 1.5k
- Epidemiology 1.5k
- Radiology, Nuclear Medicine and Imaging 1.0k
Countries citing papers authored by Jean‐Paul Sculier
This map shows the geographic impact of Jean‐Paul Sculier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jean‐Paul Sculier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jean‐Paul Sculier more than expected).
Fields of papers citing papers by Jean‐Paul Sculier
This network shows the impact of papers produced by Jean‐Paul Sculier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jean‐Paul Sculier. The network helps show where Jean‐Paul Sculier may publish in the future.
Co-authorship network of co-authors of Jean‐Paul Sculier
This figure shows the co-authorship network connecting the top 25 collaborators of Jean‐Paul Sculier. A scholar is included among the top collaborators of Jean‐Paul Sculier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jean‐Paul Sculier. Jean‐Paul Sculier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [Management of resectable non-small cell lung cancer. Guidelines of clinical practice made by the European Lung Cancer Working Party]. | 3 |
| 2 | Les recommandations de pratique clinique de l'European Lung Cancer Working Party: Mises à jour. | 1 |
| 3 | 72 | |
| 4 | El valor de captacion estandarizado (SUVmax) del tumor primario medido con tomografia de emission de postrones con fluorodesoxiglucosa (FDG-PET) tiene valor pronostico para la supervivencia en el cancer de pulmon no microcitico (CPNMC): Una revision sistematica y metaanalisis (MA) del European Lung Cancer Working Party para el IASLC Lung Cancer Staging Project | 1 |
| 5 | 20 | |
| 6 | 0 | |
| 7 | Prognostic role of thyroid transcription factor (TTF-1) in lung cancer: a meta-analysis of the published studies | 0 |
| 8 | 2 | |
| 9 | Complications aiguës des cancers broncho-pulmonaires primitifs. | 1 |
| 10 | VEGF et survie des patients atteints d'un cancer pulmonaire. Revue systématique avec méta-analyse. | 53 |
| 11 | Reflections on the current staging system for lung cancer | 1 |
| 12 | Citation factors are not reflecting the methodological quality of lung cancer randomised trials. | 3 |
| 13 | 202 | |
| 14 | [The role of chemotherapy in the treatment of non-metastatic, non-small cell bronchial cancers]. | 4 |
| 15 | 14 | |
| 16 | Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy | 2 |
| 17 | Doit-on améliorer la classification TNM de 1997? | 1 |
| 18 | Phase II and III studies with new drugs for non small cell lung carcinoma: a systematic review of the literature with a methodology quality assessment | 1 |
| 19 | [Critical review of the randomized trials assessing the role of adjuvant thoracic irradiation and chemotherapy in the treatment of limited-stage small cell lung cancer]. | 15 |
| 20 | Phase I study of Amphotericin B lipid complex with ABLC pharmacokinetics in patients receiving antineoplastic therapy | 12 |
About Jean‐Paul Sculier
Jean‐Paul Sculier is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Medical Terminology, having authored 228 papers that have together received 8.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (94 papers), Lung Cancer Research Studies (82 papers) and Lung Cancer Diagnosis and Treatment (64 papers). The work is most often cited by research in Oncology (4.3k citations), Pulmonary and Respiratory Medicine (4.7k citations) and Otorhinolaryngology (220 citations). Jean‐Paul Sculier has collaborated with scholars based in Belgium, France and United States. Frequent co-authors include Jean Klášterský, Marianne Paesmans, Thierry Berghmans, Anne‐Pascale Meert, Céline Mascaux, P Libert, G. Bureau, J Thiriaux, G Dabouis and Vincent Ninane. Their work appears in journals such as Nature, New England Journal of Medicine and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.